1. 0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer. (1st October 2006) Authors: Nishimura, M.; Furumoto, H.; Abe, A.; Yoshida, K.; Irahara, M. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 3 Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component. Issue 1 (1st January 2008) Authors: Abe, A.; Furumoto, H.; Yoshida, K.; Nishimura, M.; Irahara, M.; Kudo, E.; Sano, T. Journal: International journal of gynecological cancer Issue: Volume 18:Issue 1(2008) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. V-111SLEEVE LEFT LOWER LOBE AND LINGULAR SEGMENTAL RESECTION AFTER INDUCTION CHEMORADIOTHERAPY. (24th August 2016) Authors: Ito, Hiroyuki; Nakayama, H.; Nishii, T.; Isaka, T.; Furumoto, H.; Matsuzaki, T.; Hashimoto, M. Journal: Interactive cardiovascular and thoracic surgery Issue: Volume 23(2016:Jul.)Supplement 1 Page Start: i30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗